GC
Grimes & Company’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-48,173
| Closed | -$1.6M | – | 217 |
|
|
2017
Q2 | $1.6M | Sell |
48,173
-1,707
| -3% | -$56.7K | 0.18% | 92 |
|
|
2017
Q1 | $1.6M | Buy |
49,880
+10,692
| +27% | +$343K | 0.18% | 91 |
|
|
2016
Q4 | $1.42M | Sell |
39,188
-683
| -2% | -$24.8K | 0.16% | 95 |
|
|
2016
Q3 | $1.83M | Sell |
39,871
-3,653
| -8% | -$168K | 0.25% | 85 |
|
|
2016
Q2 | $2.19M | Sell |
43,524
-10,361
| -19% | -$520K | 0.29% | 83 |
|
|
2016
Q1 | $2.88M | Buy |
53,885
+7,111
| +15% | +$380K | 0.37% | 70 |
|
|
2015
Q4 | $3.07M | Sell |
46,774
-64
| -0.1% | -$4.2K | 0.41% | 67 |
|
|
2015
Q3 | $2.65M | Sell |
46,838
-2,551
| -5% | -$144K | 0.34% | 74 |
|
|
2015
Q2 | $2.92M | Buy |
49,389
+478
| +1% | +$28.3K | 0.41% | 72 |
|
|
2015
Q1 | $3.05M | Buy |
48,911
+1,139
| +2% | +$71K | 0.73% | 58 |
|
|
2014
Q4 | $2.75M | Sell |
47,772
-2,174
| -4% | -$125K | 0.71% | 61 |
|
|
2014
Q3 | $2.68M | Sell |
49,946
-1,182
| -2% | -$63.5K | 0.7% | 61 |
|
|
2014
Q2 | $2.68M | Buy |
51,128
+969
| +2% | +$50.8K | 0.7% | 60 |
|
|
2014
Q1 | $2.65M | Buy |
50,159
+1,374
| +3% | +$72.6K | 0.74% | 55 |
|
|
2013
Q4 | $1.96M | Sell |
48,785
-71,823
| -60% | -$2.88M | 0.58% | 60 |
|
|
2013
Q3 | $4.56M | Buy |
120,608
+8,575
| +8% | +$324K | 1.54% | 30 |
|
|
2013
Q2 | $4.39M | Buy |
+112,033
| New | +$4.39M | 1.6% | 26 |
|